This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Chr. Hansen A/s. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovations of Anders Damholt
Introduction
Anders Damholt is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of probiotics, particularly through his innovative patent related to a specific bacterial strain. His work is essential in advancing the understanding and application of probiotics in medical treatments.
Latest Patents
Anders Damholt holds a patent for a probiotic strain and compositions comprising said strain, specifically deposited as DSM 32356. This invention relates to compositions that may include at least one other bacterial strain and/or a compound such as an NSAID, including acetylsalicylic acid (aspirin). The primary focus of this invention is to support the defense against intestinal tissue damage, such as mucosal breaks or lesions, particularly in connection with NSAID administration. The method involves administering the strain deposited as DSM 32356 to subjects in need of such treatment.
Career Highlights
Anders Damholt is associated with Chr. Hansen A/S, a company renowned for its work in bioscience and probiotics. His role at the company has allowed him to explore and develop innovative solutions that address critical health issues related to intestinal health.
Collaborations
Anders collaborates with talented coworkers, including Anja Wellejus and Vibeke Westphal Stennicke. Their combined expertise contributes to the advancement of research and development in the field of probiotics.
Conclusion
Anders Damholt's contributions to the field of probiotics through his innovative patent demonstrate his commitment to improving health outcomes. His work at Chr. Hansen A/S and collaborations with skilled professionals further enhance the impact of his inventions.